Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1996;11(3):239–247. doi: 10.1007/BF02237961

Methylmalonic and malonic aciduria in a dog with progressive encephalomyelopathy

Michael Podell 1,✉, G Diane Shelton 2, William L Nyhan 3, Susan O Wagner 1, Anne Genders 4, Michael Oglesbee 5, William R Fenner 1
PMCID: PMC7089197  PMID: 8869944

Abstract

A 12 week old female Labrador retriever dog with signs of progressive diffuse degeneration of the brain and spinal cord was found to have methlymalonic and malonic aciduria. Over a 5 month period, the dog developed neurologic signs compatible with disease of the central nervous system with predominant diffuse cerebral and right lateralizing brainstem deficits. Gross pathological examination of the brain showed that the lateral, third, and fourth ventricles of the brain were markedly enlarged and associated with white and grey matter atrophy. Syringomyelia and hydromyelia of the central canal into the dorsal funiculus of the spinal cord beginning at the level of the cervical intumescence and extending to the lumbar intumescence was also present. Significant biochemical abnormalities include methylmalonic and malonic aciduria, mild lactic and pyruvic aciduria. There was also accumulation of citric acid cycle intermediates including succinic, aconitic, and fumaric acids. Disordered fatty acid oxidation was suggested by increased excretion of adipic, ethylmalonic, suberic and sebacic acids. Neither ketoacidosis nor hyperammonemia were present, and serum cobalamin levels were normal. Overall, this dog demonstrates an inborn error of metabolism resulting in abnormal organic acid accumulation associated with a neurodegenerative disease.

Keywords: Methylmalonic aciduria, malonic aciduria, encephalomyelopathy, hydrocephalus, dog

References

  1. Bieber L., Lewin L. Measurement of carnitine and 0-acylcarnitines. Methods in Enzymology. 1981;72:276–276. doi: 10.1016/s0076-6879(81)72015-9. [DOI] [PubMed] [Google Scholar]
  2. Bowen J. M. Electromyography. In: Oliver J.E., Hoerlein B.F., Mayhew I.G., editors. Veterinary Neurology. Philadelphia: W.B. Saunders; 1987. pp. 145–167. [Google Scholar]
  3. Brown G.K., Schloem R.D., Bankier A., Danks D. M. Malonyl coenzyme A decarboxylase deficiency. J. Inher. Metab. Dis. 1984;7:21–26. doi: 10.1007/BF01805615. [DOI] [PubMed] [Google Scholar]
  4. Dubowitz V. Muscle Biopsy. A Practical Approach. Philadelphia: Bailliere Tindall; 1985. [Google Scholar]
  5. Fyfc J.C., Giger U., Hall C.A., Jezyk P.F., Klumpp S.A., Levine J.S., Patterson D.F. Inherited selective intestinal cobalamin malabsorption and cobalamin deficiency in dogs. Pediatric. Res. 1991;29:24–31. doi: 10.1203/00006450-199101000-00006. [DOI] [PubMed] [Google Scholar]
  6. Haas R.H., Nyhan W.L. Disorders of Organic acids. In: Berg B., editor. Neurologic Aspects of Pediatrics. Boston: Butterworth-Heineman; 1992. pp. 47–91. [Google Scholar]
  7. Hoffman G., Aramaki S., Blum-Hoffmann E., Nyhan W.L., Sweetman L. Quantitative analysis for organic acids in biological samples: Batch isolation followed by gas chromatographic-mass spectrometric analysis. Clin. Chem. 1989;38:587–595. [PubMed] [Google Scholar]
  8. Marsden D.L., Nyhan W.L. Neurological diseases in disorders of organic acids. Current Opinion in Neurology and Neurosurgery. 1992;5:349–354. [PubMed] [Google Scholar]
  9. McPhee G.B., Logan R.W., Mitchess J. S. Malonyl coenzyme A decarboxylase deficiency. Arch. Dis. Childhood. 1993;69:433–436. doi: 10.1136/adc.69.4.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ostergaard J.R., Reske-Nielsen E.R., Nathan E., Rasmussen K. Incomplete development of the brain in a newborn with methylmalonic aciduria. Clin. Neuropathol. 1991;10:85–90. [PubMed] [Google Scholar]
  11. Ozand P.T., Gascon G.G. Organic acidurias: A review. Part 1. J. Child Neurology. 1991;6:196–219. doi: 10.1177/088307389100600302. [DOI] [PubMed] [Google Scholar]
  12. Ozand P.T., Gascon G.G. Organic acidurias: A review. Part 2. J. Child Neurology. 1991;6:288–303. doi: 10.1177/088307389100600402. [DOI] [PubMed] [Google Scholar]
  13. Ozand P.T., Nyhan W.L., Al Aqeel A., Christodoulou J. Malonic aciduria. Brain & Development. 1994;16:7–11. doi: 10.1016/0387-7604(94)90091-4. [DOI] [PubMed] [Google Scholar]
  14. Spackman D.H., Stein W.H., Moorel S.H. Automatic recording apparatus for use in the chromatography of amino acids. Anal. Chem. 1958;30:1190–1205. [PubMed] [Google Scholar]
  15. Wajner M., Brites E.C., Dutra J.C. Diminished concentration of ganglioside N-acetylneuraminic acid (G-NeuAc) in cerebellum of young rats receiving chronic administration of methylmalonic acid. J. Neurol. Sci. 1988;&:233–238. doi: 10.1016/0022-510x(88)90159-1. [DOI] [PubMed] [Google Scholar]

Articles from Metabolic Brain Disease are provided here courtesy of Nature Publishing Group

RESOURCES